Vic Schmitt

Vic Schmitt

Signal active

Advisor

Contact Information

Social

Primary Organization

Bay City Capital

Bay City Capital

Founded

1997

Investment

131

Lead investment

25

Exits

63

Employees

11-50

Industry

Biotechnology

Bio

Vic Schmitt, MBA, a Venture Partner with Bay City Capital, was formerly President, Venture Management, Baxter Healthcare Corporation. He held this position since 1994 and was responsible for the creation and management of Baxter Healthcare’s interests in development-stage biotech companies. Prior to this position, he held the operating position of President, Baxter Biotech Europe. He has also served as Vice President, Business Development and Finance for Baxter Healthcare's Blood Therapy Group. Mr. Schmitt joined Baxter Healthcare from a sixteen-year career with the American Red Cross Blood Services. At the Red Cross Blood Services, he held positions in marketing and operations. At the time of his departure, he was Vice President, Blood Services with responsibility for the organization’s national blood services program. Mr. Schmitt holds a BS from the University of Virginia and an MBA from the University of Maryland. He serves on the board of directors of a number of development-stage biotech companies.

Location

Chicago, Illinois, United States, North America

Jobs history

0

N/A

Educations

1

University of Virginia

Commerce

Profile Resume

Vic Schmitt is the Advisor at Bay City Capital, based in United States, North America. With a background in Biotechnology, Vic Schmitt has a rich history of leadership and innovation.Vic Schmitt studied BS Commerce at University of Virginia. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Products and Innovations

0

There is no product and inovations for this profile.

Achievements

0

There is no Achievements for this profile.

Publications

0

There is no publication for this profile.

Recent Activity

There is no recent news or activity for this profile.